| Pharmaceuticals in Australia: developments in regulation and governance. | |
| | |
MedLine Citation:
|
PMID: 15081192 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The pharmaceutical domain represents a type of internationalised policy network theorised in recent writings on neo-liberalism, neo-corporatism and governance. This article presents an analysis of developments in prescription drug regulation in Australia. A relatively stable, state-managed pattern of interaction has been superseded by less closed exchange, and the government itself has fragmented into agencies pursuing different objectives. Developments in the three core regulatory areas are described: safety and efficacy controls, social policy (access and equity), and state support for industry (economic) development. Consensus-building occurs within the context of the National Medicines Policy. The pharmaceutical industry, represented by Medicines Australia, has a stake in all aspects of pharmaceutical policy and regulation, and draws upon unique resources (expertise and lobbying capacity). The context for the developments described is Australia's abandonment of a protectionist version of the Keynesian welfare national state in favour of the model of the competition state, which is oriented towards support for the growth of high technology industries such as pharmaceuticals, premised on partnerships with business. |
| | |
Authors:
|
Hans Lofgren; Rebecca de Boer |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Social science & medicine (1982) Volume: 58 ISSN: 0277-9536 ISO Abbreviation: Soc Sci Med Publication Date: 2004 Jun |
Date Detail:
|
Created Date: 2004-04-14 Completed Date: 2004-08-03 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8303205 Medline TA: Soc Sci Med Country: England |
Other Details:
|
Languages: eng Pagination: 2397-407 Citation Subset: IM |
Affiliation:
|
School of Social and International Studies, Deakin University, Geelong VIC 3217, Australia. hans.lofgren@deakin.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Australia Drug Approval* Drug Industry / organization & administration* Health Care Surveys Health Policy Humans Insurance, Pharmaceutical Services* National Health Programs / legislation & jurisprudence* Organizational Innovation Policy Making Program Development Program Evaluation Questionnaires Technology, Pharmaceutical |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Scope of pharmacy ethics-an evaluation of the international research literature, 1990-2002.
Next Document: The failure of pharmaceuticals and the power of plants: medicinal discourse as a critique of moderni...